Introducing Aura Inhale, Relex’s first major health and wellness partner

Today we’re taking a deep dive in the first partnership of Relex’s health branch, Aura Inhale.

Aura Inhale was founded upon the work of Dr. Stephen Boyd, an American nuclear chemist in the field of thorium molten salt nuclear reactors and the use of nuclear reactors in outer space.

Boyd’s scientific knowledge led to a revolutionary discovery: the alchemist key of how to transform almost any compound into an inhalable form. Boyd’s technique has never been done before, and the founders hold a 20 year patent (until the year 2037) on the process.

Relex’s partnership with Aura Inhale is truly revolutionary, and it’s poised to become the undisputed leader in the inhalables field.

In fact, Aura Inhale’s technology, compositions, and delivery system are so game-changing that the UK Ministry of Defense field tested an Aura-branded product with its troops. The UK MOD not only tried the product, but also ranked Aura Inhale’s product as effective in the field. The MOD shares the results of this testing with its counterparts in the United States.

As for access, Her Majesty’s Revenue & Customs in the UK cleared Aura Inhale products for unlimited importation into the United Kingdom, opening doors wide to distributors.

Aura Inhale also recently acquired the patent for inhalable sildenafil from Pfizer, more commonly known as inhalable Viagra.

Aura Inhale’s technology greatly differs from its competitors, many of which powderize their compounds for inhalable forms. Powderized inhalables can be less effective. Also, not everything can be inhaled in powderized form.

Traditional pharma companies have to create inhalable products one at a time. For each product they need to start from scratch to figure out how to make an inhalable version of each separate inhalable product on their own.

Boyd’s knowledge of nuclear chemistry led to his revolutionary invention, and the patented technique does not result in a powder, making it safer and healthier for use. Aura also avoids anything with heavy metals, propylene glycol, sugars, and salts — none of these are meant to be inhaled and aren’t good for the human body. Aura Inhale sets the gold standard for inhalables, only vaporizing those components that can promote a healthy lifestyle.

And Aura is the only company on the market with a golden key approach where the same process yields a mind-boggling number of inhalable products — able to use the same inhalable conversion technique over and over to create inhalable products quicker, cheaper, and more effective than ever before. This patented technique is the most effective solution in the market for rapid conversion of supplements and medicines for wellness and pharmaceutical partners.

With over a trillion different pharmacological options, though, which products should actually be funded and created?

This is where holders of the Relex health token take control. As a token holder, you are part of the groundbreaking R&D division for Aura Inhale: proposing products, funding research and development, creating the brand and labeling, and taking control of distribution channels for your newly created product.

The health token operates on an economic model that steers clear from any security implications, and it should remain as a utility token perpetually.

Inhalables are more potent than their pill forms, and the way they are metabolized by the body is often much quicker and more effective. Who knows, perhaps an inhalable you create could save someone’s life one day with its quick metabolization time.

Only a few compounds are currently off the table, although processes for making them inhalable are still being researched. Currently, hormones and amino acids (as well as some other acids) cannot be made inhalable.

Aside from that, the pharmacopia cornucopia is your toolbox.

Most compounds will cost $60,000 for development and take around two months for the entire development process. More complex compounds can take up to six months and will have development costs in the lower-six-figure range. Part of this time will be used for rigorous safety testing, as inhalables are significantly more potent than their pill-based forms.

Considering that the global dietary supplements market alone was valued at 132.8 billion USD in 2016, creating the next big supplement can not only make life better for people, it can be profitable too.

So, what will you create?

With Relex Life, Create Life.

Ticker: RLXI

To join the conversation, visit the Relex community:

Telegram: https://t.me/relex_core.

Relex website: www.relex.io

Relex Twitter: @RelexTalk

Relex Facebook: @RelexTalk

Relex SubReddit: https://www.reddit.com/r/RelexRLX/